E2F1 and chronic myelogenous leukemia, BCR-ABL1 positive: In terms of cell cycle regulation, the E2F1 signaling pathway was found to be deregulated in CML SPCs, and inhibition of E2F1 led to cell cycle arrest and induced blockade of proliferation (21).